Formerly at NCI and Head of Hematology at Georgetown University Hospital, 5 decades developing new drugs for CLL and lymphoma and establishing response criteria.
Talks (16)
Air Time: 23:36:27
LOTIS-7 Study in DLBCL
Feb 02
ROSEWOOD Study Analysis
Feb 02
Zanu/Sonrotoclax in CLL
Feb 02
AMPLIFY Phase III Trial
Feb 02
Epcoritamab in elderly LBCL
Jan 19
R-glofit-pola in elderly LBCl
Jan 19
Resistance to Pirtobrutinib
Jan 17
Limited duration acalabrutinib
Jan 17
Pirtobrutinib vs BR in CLL
Jan 17
Bexobrutideg in CLL
Jan 17
Pirtobrutinib vs Ibrutinib in CLL
Jan 16
